Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Sanofi
Sanofi
10 clinical trials to watch in the first half of 2023
BioPharma Dive
Tue, 01/3/23 - 10:57 am
clinical trials
Alzheimer's disease
obesity
Huntington's disease
M&A
AstraZeneca
Daiichi Sankyo
Nimbus Therapeutics
Takeda
Eli Lilly
Sanofi
Regeneron
Moderna Therapeutics
Gilead Sciences
Pfizer
Roivant
Alnylam
uniQure
Could This Drug News Give a Lift to Eli Lilly Stock?
Motley Fool
Mon, 01/2/23 - 06:27 pm
Eli Lilly
Rezvoglar
diabetes
Sanofi
Lantus
biosimilars
long-acting insulin
Sanofi expands on Innate tumor collab with fresh $1.44B deal for more NK engagers
Fierce Biotech
Mon, 12/19/22 - 11:19 am
Sanofi
Innate Pharma
natural killer cells
solid tumors
First Protein Degrader Tested Outside Oncology Yields Promising Results
BioSpace
Wed, 12/14/22 - 07:23 pm
Kymera Therapeutics
Sanofi
protein degradation
hidradenitis suppurativa
atopic dermatitis
KT-474
Sanofi sets Revolution back, sending $550M SHP2 inhibitor deal to the docks
Fierce Biotech
Fri, 12/9/22 - 10:26 am
Sanofi
Revolution Medicines
SHP2 inhibitors
RMC-4630
GSK, Sanofi, Takeda sign with Singapore partnership to advance biologic manufacturing
Fierce Pharma
Tue, 12/6/22 - 08:54 pm
GSK
Sanofi
Takeda
Singapore
biologics
Janssen Bows Out as Contender for Horizon Therapeutics Buyout
BioSpace
Mon, 12/5/22 - 10:59 am
Horizon Therapeutics
M&A
Agmen
Sanofi
Janssen
JNJ
With buyout on Horizon, Amgen and Sanofi eye cash plays for rare disease drug maker
Fierce Pharma
Fri, 12/2/22 - 11:13 am
Horizon Therapeutics
Sanofi
Amgen
M&A
UK regulators warn of ocular side effects after treatment with Sanofi's Dupixent
Fierce Pharma
Thu, 12/1/22 - 10:43 am
Regeneron
Sanofi
Dupixent
UK
side effects
Large pharmas probe takeover of Horizon Therapeutics
BioPharma Dive
Wed, 11/30/22 - 10:58 am
Horizon Pharma
M&A
JNJ
Sanofi
Amgen
Sanofi's sleeping sickness drug cures 95% of people in phase 2/3 trial, boosting plan to stop transmission
Fierce Biotech
Wed, 11/30/22 - 10:50 am
Sanofi
sleeping sickness
acoziborole
clinical trials
Sanofi moves into swanky new Paris HQ designed around hybrid work and sustainability
Fierce Pharma
Mon, 11/28/22 - 10:44 am
Sanofi
France
Paris
headquarters
AstraZeneca and Sanofi win big as Europe's human medicines committee endorses approvals, label expansions
Fierce Pharma
Mon, 11/14/22 - 07:10 pm
Europe
AstraZeneca
Sanofi
COVID-19
cancer
GSK
Regeneron
Dupixent nears EU approval for rare skin disease prurigo nodularis
Pharmaphorum
Mon, 11/14/22 - 10:52 am
Sanofi
Regeneron
Dupixent
Europe
prurigo nodularis
Sanofi, GSK crash the COVID-19 vaccine party late with a world-first nod for their next-gen booster
Fierce Pharma
Thu, 11/10/22 - 10:22 pm
Sanofi
GSK
COVID-19
Europe
vaccines
boosters
ASH preview – waiting for Editas
EP Vantage
Wed, 11/9/22 - 10:40 am
ASH 2022
sickle cell disease
Bluebird Bio
Sangamo BioSciences
Novartis
Editas Medicine
gene therapy
Vertex Pharmaceuticals
Sanofi
Sanofi Reaffirms Commitment to AI Drug Discovery with $1.2B Insilico Pact
BioSpace
Tue, 11/8/22 - 10:30 pm
Sanofi
artificial intelligence
Insilico
drug discovery
R&D
Sanofi Secures Access to Salipro's Protein Stabilization Tech in R&D Deal
BioSpace
Tue, 11/8/22 - 10:25 pm
Sanofi
Salipro
R&D
Amgen's Supreme Court bid answered in long-running Repatha patent feud against Sanofi, Regeneron
Fierce Pharma
Mon, 11/7/22 - 10:55 am
Amgen
Repatha
patents
Supreme Court
Sanofi
Regeneron
Sanofi, AstraZeneca clinch first OK for RSV antibody — just as vaccines line up at regulators
Endpoints
Fri, 11/4/22 - 10:21 am
Sanofi
AstraZeneca
RSV
nirsevimab
Europe
vaccines
Pages
« first
‹ previous
…
5
6
7
8
9
10
11
12
13
…
next ›
last »